Adaptive Biotechnologies (ADPT) Misses Q4 EPS by 18c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $20.96 +3.51%
EPS Growth %: +17.6%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +17.6%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.48), $0.18 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.78 million versus the consensus estimate of $48.45 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Argus starts SpaceX at Hold, sees record IPO as a multi-year re-rating challenge
- JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
